Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Alert Triggered for CVD Equipment Corp.
CVV Reached a New 52 Week High at $9.14
CVV rose 3.6% to a new 52 week high of $9.14. During the last 52 weeks, CVV's price has ranged from $2.15 on August 16, 2006 to today's high of $9.14.
Additionally, over the last 12 months, CVV has increased 131.98%.
Please note you will receive only one "New 52 Week High" alert per day for CVD Equipment Corp.
Alert Triggered for CVD Equipment Corp.
CVV Reached a New 52 Week High at $8.75
CVV rose 4.6% to a new 52 week high of $8.75. During the last 52 weeks, CVV's price has ranged from $2.15 on August 16, 2006 to today's high of $8.75.
Additionally, over the last 12 months, CVV has increased 124.16%.
Please note you will receive only one "New 52 Week High" alert per day for CVD Equipment Corp.
Alert Triggered for CVD Equipment Corp.
CVV Reached a New 52 Week High at $8.25
CVV rose 5.9% to a new 52 week high of $8.25. During the last 52 weeks, CVV's price has ranged from $2.15 on August 16, 2006 to today's high of $8.25.
Additionally, over the last 12 months, CVV has increased 111.54%.
Please note you will receive only one "New 52 Week High" alert per day for CVD Equipment Corp.
Nice post.
Interesting read:
Nanotech Wins a Convert
By Jack Uldrich
The Motley Fool
April 18, 2007
Billionaire investor Wilbur Ross, who has made most of his money restructuring failed companies in such unglamorous industries as steel, coal, and most recently, textiles, is not the kind of guy to jump on the latest technology fad. Therefore, when someone like Ross begins investing in nanotechnology, I believe it serves as further validation that the technology is moving into the mainstream.
Yesterday, I had the opportunity to hear Ross deliver a keynote presentation at the sixth NanoBusiness Alliance conference in New York City. In his talk, he explained how he pretty much stumbled into nanotechnology when he acquired Burlington Industries, a textile manufacturer, in a bankruptcy deal a few years ago. As part of that deal, he also acquired Nano-Tex, which Burlington then owned.
Nano-Tex has successfully been incorporating its nanofibers into a variety of stain-resistant garments, including many from Brooks Brothers, Adidas, Eddie Bauer, and Lee Jeans.
The technology itself was enough to catch Ross' attention, but what really made his financial antennae perk up was its tremendous growth potential. In 2007, Ross estimates that nano-enabled textiles represent roughly $11 billion in sales. By 2012, he expects that figure to jump to $120 billion.
This growth, in turn, caused Ross to direct his investment team to scour the landscape for other such nanotechnology opportunities. As a result, he has made sizeable investments in five other private nanotech companies in the past year.
What caught my attention -- and what I think should interest to Foolish readers -- is that four of the five companies he selected are already in Harris & Harris' (Nasdaq: TINY) portfolio. For the record, those four companies are Neophotonics, C-Switch, NanoOpto, and Nanosys.
My point here is that Ross is not a venture capitalist. He is a practical, experienced businessman with a great nose for turning around companies. If he's investing in nanotech, it's not because he thinks it's a fad, but because he thinks there's great value in these companies.
Most of us don't have anywhere near Ross's financial resources. But if you agree with him that there is real substance to nanotechnology, an investment in Harris & Harris represents an excellent way to piggyback on his investment expertise.
Nanophase Paints the Town
By Jack Uldrich
The Motley Fool
April 18, 2007
Nanophase Technologies (Nasdaq: NANX) picked up its pace last week, reporting that its 2006 revenue increased 32% year over year. Today, thanks to news of a major new product deal, I'm even more bullish about the company's long-term prospects.
Yesterday, while attending the NanoBusiness Alliance's annual conference in New York, I learned that Nanophase's proprietary nanoparticles are now being used in Behr's Premium Plus Ultra paint. Nanophase's nanoparticles not only lend the paint improved adhesion and anti-mildew properties, but also allow users to forgo the normal two-step priming and coating process. The new paint reportedly does both in a single step.
I don't know about you, but painting isn't one of my favorite chores. I'm willing to pay a few extra bucks for a gallon of paint if it'll help me save a couple of hours -- especially in the summer. (According to Nanophase's president, Joe Cross, Behr will indeed charge a hefty premium for this new paint).
Cross also indicated that 800 Home Depot (NYSE: HD) stores already stock Behr's new paint, with another 2,200 stores signing on in the next couple of weeks. Behr plans to launch a major marketing campaign for the new paint, according to Cross.
While Behr controls an estimated 25% of the market for external architectural paints, Nanophase isn't tied to an exclusive agreement with the company, leaving it free to sign additional agreements with rival paint firms like Sherwin Williams (NYSE: SHW), PPG (NYSE: PPG), or Benjamin Moore.
All of these factors, in turn, lead me to believe in Cross' confidence that Nanophase can increase its 2007 revenues between 40% and 50%. Combined with the company's ability to also increase its margins (since its manufacturing facilities will be running much nearer full capacity), I see a nice run ahead for the company.
Don't expect a huge jump in its stock price. But by year's end, you might be able to use some of your Nanophase profits to either paint the town for an evening, or -- if you prefer something a little more practical -- perhaps give your house a new coat of paint.
Russia to invest $1B in nanotechnology
BusinessWeek.com
April 18, 2007, 12:47PM EST
Russia will pour over $1 billion into equipment for nanotechnology research over the next three years as it uses massive oil and gas export earnings to diversify an economy now heavily dependent on raw materials, First Deputy Prime Minister Sergei Ivanov said Wednesday.
"Nanotechnology is a very promising scientific and technical field, capable of fundamentally changing the model of the Russian economy ... from a fuel economy to an economy of the future," Ivanov said after a meeting Wednesday at the Kurchatov nuclear and scientific research institute, which was attended by President Vladimir Putin.
Nanotechnology is an emerging field that works with microscopic particles the size of atoms.
Ivanov, considered a possible candidate for Kremlin support to replace Putin after presidential election next March, said Putin had chosen him to head a council that will supervise spending on the nanotechnology effort under a program being developed by the government.
He said spending would amount to 28 billion rubles ($1.1 billion) over the next three years.
Since the start of Putin's presidency in 2000, Russia has earned an estimated $750 billion from oil and gas sales, according to Moscow-based Alfa Bank. Putin has repeatedly stressed the importance of freeing the economy from its dependence on commodities markets and turning it toward a more high-tech, knowledge-based model.
"Russia's economic potential has been restored, the possibilities for major scientific research are opening up," Putin said. "The concentration of our resources should stimulate the development of new technologies in our country. This will be key also from the point of view of the creation the newest, modern and supereffective weapons systems."
Ivanov predicted that 90 percent of nanotechnology developments would be used for civilian purposes and 10 percent for military purposes.
The nanotechnology effort will be coordinated at the Kurchatov institute, Ivanov said.
Anybody see the action of that other nanotech capital equipment stock that reported EPS of 8 cents for Q4/06 and broke $8 today, CVV? This could be a roadmap for MFIC's stock price should new management realize its earnings potential in short order. MFIC is a scremaing buy at the present price of 1.76 IMHO.
SOTK moving 1.23/1.30 - The part of their latest PR news that I like is all of the new applications they are breaking into including nanotechnology:
"The SonoDry series of spray dryers is of particular importance to Product and Process developers in the following industries: Pharmaceuticals (e.g. for drug actives and intermediates, enzymes and low molecular weight proteins), Foods (e.g. for nutriceuticals, herbal extracts and flavors) and Specialty Chemicals (e.g. for fragrances, Cosmetics ingredients and nano-scale particles)."
Alert Triggered for CVD Equipment Corp.
CVV Reached a New 52 Week High at $7.82
CVV rose 5.9% to a new 52 week high of $7.82. During the last 52 weeks, CVV's price has ranged from $2.15 on August 16, 2006 to today's high of $7.82.
Additionally, over the last 12 months, CVV has increased 98.19%.
Please note you will receive only one "New 52 Week High" alert per day for CVD Equipment Corp.
Sono-Tek Offers New Line of Ultrasonic Spray Dryers for Laboratory Use
Tuesday April 17, 1:13 pm ET
MILTON, N.Y., April 17 /PRNewswire-FirstCall/ -- Sono-Tek Corporation (OTC Bulletin Board: SOTK - News), announced today the release of a new line of Laboratory Ultrasonic Spray Drying Systems -- The SonoDry Ultrasonic Spray Dryer. This new spray dryer is available in three sizes, providing the ability to choose the proper size machine for differing requirements:
-- SonoDry 750 (up to 750 ml/hr)
-- SonoDry 1000 (up to 1,000 ml/hr)
-- SonoDry 1500 (up to 1,500 ml/hr)
All SonoDry Spray Dryers are supplied with Sono-Tek's unique non-clogging ultrasonic atomizing nozzle incorporated into them. SonoDry systems also have the ability to use a traditional twin fluid air atomizing nozzle system as well. Nozzle requirements can be specified by the customer depending on application needs. The machines can handle both aqueous and solvent based liquids. All systems include software that allows for recipe storage and complete data logging of all system functions. A fully integrated magnetic stirrer and hot plate are standard on both the SonoDry 1000 and SonoDry 1500. SonoDry systems use a high yield twin cyclone capture system. Yields exceeding 95% can be achieved for many applications.
Designed for flexibility to meet a variety of experimental needs, these systems can be operated with an optional congealing nozzle for freeze drying applications, with counter current nozzles to create larger particles, and with a Teflon membrane scrubber to capture particles from sub-micron to nano- particle sizes. These features make the system ideal for a wide range of spray drying processes for R&D and small batch production needs.
The SonoDry series of spray dryers is of particular importance to Product and Process developers in the following industries: Pharmaceuticals (e.g. for drug actives and intermediates, enzymes and low molecular weight proteins), Foods (e.g. for nutriceuticals, herbal extracts and flavors) and Specialty Chemicals (e.g. for fragrances, Cosmetics ingredients and nano-scale particles).
According to Dr. Christopher L. Coccio, President and CEO, "Sono-Tek has had several years of spray drying experience in the US market, integrating our ultrasonic nozzles into traditional spray dryers to help customers achieve benefits such as non-clogging performance, which is particularly important with some nano-particle containing liquids. The SonoDry system is capable of achieving greater particle uniformity compared to traditional spray drying methods, which can be important for some applications. We look forward to presenting this new and versatile product to the global market."
More information on the new SonoDry product line can be found at the following location on our website: http://www.sono-tek.com/sonodry/index.php, or by contacting Dr. Christopher L. Coccio at 845-795-2020.
Sono-Tek Corporation is a leading developer and manufacturer of liquid spray products based on its proprietary ultrasonic nozzle technology. Founded in 1975, the Company's products have long been recognized for their performance, quality and reliability.
This press release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, competitive and technological developments affecting the Company's operations or the demand for its products; timely development and market acceptance of new products; adequacy of financing; capacity additions and the ability to enforce patents. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-KSB and Form 10-QSBs containing additional important information.
--------------------------------------------------------------------------------
Source: Sono-Tek Corporation
shmoopy, can you post a list of who's who at the conference in NYC?
It's nanotech day on CNBC. No surprise there.
Posted by: Dr Worm
In reply to: shmoopy38 who wrote msg# 1051 Date:4/13/2007 9:55:54 AM
Post #of 1056
NanoBusiness 2007, Nanotechnology's Foremost Business Conference, Returns to New York City Next Week
Last update: 4/13/2007 9:37:05 AM
NEW YORK, Apr 13, 2007 (BUSINESS WIRE) -- The NanoBusiness Alliance today announced that its 6th annual NanoBusiness 2007 conference will be returning to New York City next week, being held at the Marriott Marquis Hotel from April 15 - 17. NanoBusiness 2007 will be attended by hundreds of CEOs, scientists, engineers, business leaders, government officials and investors who will participate in three intensive days of seminars, presentations and networking events designed to provide attendees with the information required to move research and application development to commercialization, as well as to showcase the ongoing integration of nanotech products into the global economy. "This is our most comprehensive conference to date, focusing on how the ongoing development of nanotechnology is having significant impact on a wide variety of industries while improving sustainability," said Vincent Caprio, Event Director. "From keynote addresses by CTOs of major corporations, to presentations by CEOs from nanotech's brightest new companies, NanoBusiness 2007 will provide attendees with an up-to-date and thorough snapshot on the state of nanotech commercialization." Event highlights include: -- Keynote addresses by Uma Chowdry, Sr. VP and CTO - Dupont; Dr. Ray Johnson, Sr. VP and CTO - Lockheed Martin; Dr. Hans Stork, Sr. VP and CTO - Texas Instruments; Wilbur Ross, Jr., billionaire investor and Chairman/CEO - WL Ross & Co.; Keith Blakely, CEO - NanoDynamics; and Warren Packard, Managing Director, Draper Fisher Jurvetson -- Conference sessions highlighting nanotech's impact on Medical Diagnostics, Solar Energy, Green Architecture, Auto Emissions, Memory, Displays and more -- Investment forums focused on public companies, electronics, cleantech, medicine, and advanced materials -- Special NASDAQ luncheon focusing on "Exit Strategies in Public Companies" -- Sunday Pre-conferences on "Nano 101" and Nano Policy -- Series of sessions on Nanotech Advances in France, highlighting collaborative R&D programs and company presentations "This year's NanoBusiness 2007 conference has attracted record executive level participation from all sources, start-ups, large incumbents, venture capital firms, and institutional investors," noted Sean Murdock, Executive Director, NanoBusiness Alliance. "The sector is poised for exceptional growth, and we are excited that the NanoBusiness Conference has proven to be such an effective forum for those working to bring nanotech to the market." For complete event information, please visit . About The NanoBusiness Alliance The NanoBusiness Alliance is the industry association for the emerging nanotechnology industry. Through its extensive network of leading startups, Fortune 500 companies, research institutions, non-governmental organizations and public-private partnerships, the Alliance shapes nanotechnology policy and helps accelerate the commercialization of nanotechnology innovations. The NanoBusiness Alliance has offices in Chicago, New York, Connecticut and Washington, DC. For more information, visit . SOURCE: NanoBusiness Alliance
Schwartz Public RelationsSteven Wright-Mark, 212-677-8700 ext. 29steven@schwartzpr.comCopyright Business Wire 2007
TDON
I usually shy away from Pinks but this company has peaked my interest. Any holders here at .75?
NANX has been initiated by First Albany as a buy.
Fri Apr 13 06:35:29 2007
Content provided by Briefing.com, a leading Internet provider of Live market analysis. Copyright © 2002 Briefing.com, Inc. All rights reserved.
TINY has been initiated by First Albany as a buy.
Fri Apr 13 06:35:41 2007
Content provided by Briefing.com, a leading Internet provider of Live market analysis. Copyright © 2002 Briefing.com, Inc. All rights reserved.
NanoBusiness 2007, Nanotechnology's Foremost Business Conference, Returns to New York City Next Week
Last update: 4/13/2007 9:37:05 AM
NEW YORK, Apr 13, 2007 (BUSINESS WIRE) -- The NanoBusiness Alliance today announced that its 6th annual NanoBusiness 2007 conference will be returning to New York City next week, being held at the Marriott Marquis Hotel from April 15 - 17. NanoBusiness 2007 will be attended by hundreds of CEOs, scientists, engineers, business leaders, government officials and investors who will participate in three intensive days of seminars, presentations and networking events designed to provide attendees with the information required to move research and application development to commercialization, as well as to showcase the ongoing integration of nanotech products into the global economy. "This is our most comprehensive conference to date, focusing on how the ongoing development of nanotechnology is having significant impact on a wide variety of industries while improving sustainability," said Vincent Caprio, Event Director. "From keynote addresses by CTOs of major corporations, to presentations by CEOs from nanotech's brightest new companies, NanoBusiness 2007 will provide attendees with an up-to-date and thorough snapshot on the state of nanotech commercialization." Event highlights include: -- Keynote addresses by Uma Chowdry, Sr. VP and CTO - Dupont; Dr. Ray Johnson, Sr. VP and CTO - Lockheed Martin; Dr. Hans Stork, Sr. VP and CTO - Texas Instruments; Wilbur Ross, Jr., billionaire investor and Chairman/CEO - WL Ross & Co.; Keith Blakely, CEO - NanoDynamics; and Warren Packard, Managing Director, Draper Fisher Jurvetson -- Conference sessions highlighting nanotech's impact on Medical Diagnostics, Solar Energy, Green Architecture, Auto Emissions, Memory, Displays and more -- Investment forums focused on public companies, electronics, cleantech, medicine, and advanced materials -- Special NASDAQ luncheon focusing on "Exit Strategies in Public Companies" -- Sunday Pre-conferences on "Nano 101" and Nano Policy -- Series of sessions on Nanotech Advances in France, highlighting collaborative R&D programs and company presentations "This year's NanoBusiness 2007 conference has attracted record executive level participation from all sources, start-ups, large incumbents, venture capital firms, and institutional investors," noted Sean Murdock, Executive Director, NanoBusiness Alliance. "The sector is poised for exceptional growth, and we are excited that the NanoBusiness Conference has proven to be such an effective forum for those working to bring nanotech to the market." For complete event information, please visit . About The NanoBusiness Alliance The NanoBusiness Alliance is the industry association for the emerging nanotechnology industry. Through its extensive network of leading startups, Fortune 500 companies, research institutions, non-governmental organizations and public-private partnerships, the Alliance shapes nanotechnology policy and helps accelerate the commercialization of nanotechnology innovations. The NanoBusiness Alliance has offices in Chicago, New York, Connecticut and Washington, DC. For more information, visit . SOURCE: NanoBusiness Alliance
Schwartz Public RelationsSteven Wright-Mark, 212-677-8700 ext. 29steven@schwartzpr.comCopyright Business Wire 2007
Alert Triggered for CVD Equipment Corp.
CVV Reached a New 52 Week High at $7.60
CVV rose 2.4% to a new 52 week high of $7.60. During the last 52 weeks, CVV's price has ranged from $2.15 on August 16, 2006 to today's high of $7.60.
Additionally, over the last 12 months, CVV has increased 93.59%.
Please note you will receive only one "New 52 Week High" alert per day for CVD Equipment Corp.
Thinking Small
New venture firm has a nano focus
March 30, 2007
By Sean Wolfe
Many venture capital firms like to say they never invest in sectors, but in people. If that’s the case, then the arrival of newly-minted venture firm NanoDimension should raise some eyebrows. The Cayman Island-based firm announced Wednesday it had closed its first fund at $60 million to focus exclusively on nanotechnology investments.
NanoDimension is not only one of the few VC firms to focus exclusively on the nano sector, it also plans to comb Europe and the United States for deals, making it unique among its larger, more diversified rivals. NanoDimension founder and managing director Aymeric Sallin said his firm will look for companies with near-term opportunities, whether they be in hardware or life sciences.
“There’s an explosion of opportunities in the field of molecular diagnostics,” he said. “Thanks to what’s happening in nanotechnology, you can have instruments with sensitivities that are orders of magnitude higher, and costs are decreased.”
The new fund comes at a time when investors are finding nanotech investments increasingly attractive. New York-based Lux Research estimates VCs tucked $650 million into nanotech startups in 2006, up from $480 million in 2005. Deal sizes are rising too, with average investments up 19 percent to $11.5 million in 2006.
Part of that growth is fueled by exit potential: nano IPOs have fared reasonably well in the public markets, raising an aggregate $417.2 million in 2006. Another factor is the participation of top-tier Silicon Valley venture firms.
Last June saw a $75-million third round of financing for Palo Alto, California-based Nanosolar, in which firms like Mohr Davidow Ventures, Benchmark Capital, and others placed their bets.
And this past January, there was a $100-million fourth round for U.K.-based nano-display maker Plastic Logic, where heavyweights like Oak Investment Partners, Tudor Investment, and Amadeus Capital Partners joined in the financing.
Despite the sums being poured into nano, the sector’s overall success rate could raise concerns for NanoDimension’s prospects. Of the 143 companies Lux tracks, 9 percent have gone public or been acquired, 8 percent are dead or close to it, and 83 percent continue to chug along.
Another issue facing nanotech firms is a kind of favoritism, with the top 10 percent of venture-backed startups netting a whopping 43 percent of total investment, leaving other startups starved for cash.
NanoDimension’s main limited partners include a pension fund for a Swiss bank and an unnamed scientific foundation. Given the size of the fund, Mr. Sallin said the firm will be forced to pick its bets carefully. “It’s better to be small and follow each deal very carefully, than to have the pressure to invest in too many,” he said.
Source: redherring.com
MFIC Corporation Announces Record Fiscal 2006 and Quarterly Results
Thursday March 29, 3:03 pm ET
Company Posts Significant Profit for Quarter and for Year
NEWTON, Mass.--(BUSINESS WIRE)--(OTCBB: MFIC - News) MFIC Corporation ("MFIC" or the "Company") reported today its 2006 year-end and fourth quarter financial results.
For the year ended December 31, 2006, revenues were $15.6 million, an increase of more than $4 million, or 34%, as compared with $11.6 million for the comparable period in 2005. For 2006, the Company posted net income of $1.28 million or $0.12 per diluted share, as compared with a net loss of $.989 million, or $0.10 per diluted share for fiscal 2005.
For the quarter ended December 31, 2006, the Company reported revenues of $5.04 million as compared with $3.06 million in the comparable period in 2005, representing a 64% increase. Net income in the fourth quarter of 2006 was $1.0 million, or $0.10 per diluted share, compared with a net loss of $.539 million, or $0.06 per diluted share in the comparable period in 2005. The fourth quarter 2006 results include a $228,000 income tax benefit while the fourth quarter of 2005 included an income tax provision in the amount of $262,000.
On December 31, 2006, the Company had a backlog of $3.1 million, as compared with $2.8 million at December 31, 2005 and a $4.9 million backlog at September 30, 2006.
Robert P. Bruno, President & C.O.O. stated "We are pleased with our revenue growth recorded in both the fourth quarter and 2006. The increase in the number of laboratory unit sales and, in particular, the strong demand for the Company's improved M-110EH-30 system, introduced in the last quarter of 2005 played a large part in our growth.
"The Company also delivered several production systems for Biopharmaceutical applications, one of which was our newly standardized M-7250 system. This system included our Constant Pressure feature with Ultra Clean in Place (UCIP) and Steam in Place (SIP) for aseptic processing of drugs. These features enable our pharmaceutical customers to be compliant with cGMP regulatory requirements. The new Biopharmaceutical system architecture integrates all machine controls, functions and data recording onto a single common platform."
Mr. Bruno added, "For 2007, we expect growth in new products such as our M-110EH-30, the M-7250, and standardized systems for the Biopharmaceutical industries along with others to fuel continued expansion in market share."
Irwin Gruverman, CEO and Chairman stated "We are gratified by the financial results posted for fiscal 2006. For 2006 and the fourth quarter our revenues were above our internal projections and we were solidly profitable.
In 2006 we realized, in part, the benefit of our substantial and continuing investment in R&D, infrastructure development, marketing and sales. We believe that the developments achieved in the past few years in both product improvements and equipment features, combined with ongoing applications development, will keep us in a leadership position and drive continued growth in 2007 and beyond.
We must emphasize that in 2006, and particularly in the fourth quarter, the Company benefited from a strong capital equipment demand, as evidenced by the backlog going into the fourth quarter. As a capital equipment manufacturer, future quarterly revenues may fluctuate significantly."
Mr. Gruverman added, "We continue to experience positive trends in equipment inquiry and sales quotation, sales bookings and backlog, which increased to $3.6 million as of March 23, 2007."
Fourth Quarter and 2006 Company Highlights
Sold an unprecedented number of laboratory units and experienced strong demand, in particular for the improved Model M-110EH-30 introduced in late 2005.
Introduced and shipped the first newly standardized M-7250 system for the Biopharmaceutical industry, which includes our Constant Pressure feature with Ultra Clean In Place and Steam in Place (SIP). The system incorporates our new system architecture integrating the machine, all machine controls, functions and data recording onto a single common platform. Programmable Logic Control (PLC) is also integrated to manage and record sensor signals, system alarms, and interlocks. The PLC will process all of this captured information chronologically to provide the customer with real time "Event Log" data for cGMP monitoring and to assure that the machine will perform correctly during adverse events.
Signed a new 5 year lease for the Company's administrative, sales, and manufacturing facilities which allowed us to begin a major expansion and improvement of production space and operations and to commence construction on a new, upgraded Applications Laboratory.
Achieved significantly higher quarterly bookings than in all comparable quarters in 2005, leading to achievement of two quarterly revenue records.
FORWARD LOOKING STATEMENT:
Management believes that this release contains forward-looking statements that are subject to certain risks and uncertainties including statements relating to the Company's plan to attain and/or increase operating profitability and/or to achieve net profitability. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties that could cause actual results achieved by the Company to differ materially from those described in the forward-looking statements. The Company cautions investors that there can be no assurance that the actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including but not limited to the following risks and uncertainties: (i) whether the performance advantages of the Company's Microfluidizer® materials processing equipment will be realized commercially or that a commercial market for the equipment will continue to develop, (ii) whether the performance advantages of the Company's MMR nanoparticle production systems will be realized commercially, (iii) whether the Company will be able to increase its market penetration and market share, (iv) whether the timing of orders will significantly affect quarterly revenues and resulting net income results for particular quarters which may cause increased volatility in the Company's stock price, and (v) whether the Company will have access to sufficient working capital through continued and improving cash flow from sales, and ongoing borrowing availability, the latter being subject to the Company's ability to comply with the covenants and terms of its loan agreement with its senior lender.
MFIC CORPORATION
Consolidated Condensed Statements of Operations
(in thousands, except share and per share amounts)
Year Ended Fourth Quarter Ended
December 31, December 31,
----------------------------------------------------------------------
2006 2005 2006 2005
----------------------------------------------------------------------
Revenues $15,654 $11,645 $5,040 $3,064
----------------------------------------------------------------------
Cost of goods sold 7,001 5,918 2,195 1,635
----------------------------==========================================
Gross profit 8,653 5,727 2,845 1,429
----------------------------------------------------------------------
Total operating expenses 7,449 6,498 2,064 1,701
----------------------------==========================================
Operating income (loss) 1,204 (771) 781 (272)
----------------------------------------------------------------------
Interest expense (35) (59) (6) (13)
----------------------------------------------------------------------
Interest income 50 26 19 8
----------------------------------------------------------------------
Net income (loss) from
operations before income
tax provision (benefit) 1,219 (804) 794 (277)
----------------------------------------------------------------------
Income tax (benefit)
provision (58) 185 (228) 262
----------------------------================================----------
Net income (loss) 1,277 (989) 1,022 (539)
----------------------------==========================================
Weighted average number of
common and common
equivalent shares
outstanding:
----------------------------------------------------------------------
Basic 10,012,685 9,756,221 10,079,366 9,854,068
----------------------------------------------------------------------
Diluted 10,611,635 9,756,221 10,678,316 9,854,068
----------------------------------------------------------------------
Basic amounts per common
share:
----------------------------------------------------------------------
Net income (loss) per share $0.13 $(0.10) $0.10 $(0.06)
----------------------------------------------------------------------
Diluted amounts per common
share:
----------------------------------------------------------------------
Net income (loss) per share $0.12 $(0.10) $0.10 $(0.06)
----------------------------==========================================
Condensed Consolidated Balance Sheets
December 31,
----------------------------------------------------------
2006 2005
----------------------------------------------------------
Current Assets $7,857 $5,734
----------------------------------------------------------
Current Liabilities $2,213 $1,461
----------------------------------------------------------
Stockholders' Equity $5,948 $4,426
----------------------------------------------------------
Equity Per Share $0.56 $0.45
----------------------------------------------------------
Notice to Investors/Stockholders
MFIC will hold a live conference call to discuss the Company's fourth quarter and fiscal year end financial results beginning at 1:00 PM Eastern time on April 2, 2007. The domestic call in number is (800) 370 0898 and the Conference I.D. number is 8634648. For those who cannot listen and participate in the live event, it is anticipated that a replay of the call will be available on the Company's website: www.mficcorp.com by mid-to-end of the week.
About MFIC CORPORATION
MFIC Corporation, through its Microfluidics Division, provides patented and proprietary high performance Microfluidizer® materials processing equipment to the biotechnology, pharmaceutical, chemical, cosmetics/personal care, and food industries. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products. MFIC applies its 20 years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid structures available, and has provided manufacturing systems for more than 15 years.
The Company is a leader in advanced materials processing equipment for laboratory, pilot scale and manufacturing applications, offering innovative technology and comprehensive solutions for nanoparticles and other materials processing and production. More than 3,000 systems are in use and afford significant competitive and economic advantages to MFIC equipment customers. For more information please visit http://www.microfluidicscorp.com/
Contact:
MFIC Corporation
Irwin Gruverman
CEO & Chairman
or
Robert P. Bruno
President & COO
or
Jack M. Swig
Investor Relations
617-969-5452
Fax 617-965-1213
info@mfics.com
--------------------------------------------------------------------------------
Source: MFIC Corporation
Alert Triggered for Lumera Corp.
LMRA's Trading Volume Exceeded Daily Average by 201.4%
LMRA is up $0.14 or 2.74% to $5.25 on heavy volume that exceeded its daily average by 201.4%. This performance is in-line-with the broader averages as the S&P 500 is down 0.05% on the day.
Please note you will receive only one "Trading Volume Exceeds Daily Average" alert per day for Lumera Corp.
Interesting read from TheStreet.com:
http://www.thestreet.com/_googlen/newsanalysis/general/10347242.html?cm_ven=GOOGLEN&cm_cat=FREE&....
SOTK 1.30 on the move. This could be the reason for SOTK's strength. After the close yesterday Dow Jones News reported that Abbott Labs and Medtronic are entering the drug coated stent market in addition to Boston Scientific and J&J who already market this. SOTK makes ultrasonic spray equipment to batch coat drug-eluting stents among a myriad of other products:
Stent Study Shouldn't Impact Sales Long-term
5:12 PM EDT March 27, 2007
By Val Brickates Kennedy
BOSTON (Dow Jones) -- Analysts said Tuesday that they don't expect a long-term impact on stent sales from the recent release of a major study showing stent therapy doesn't ward off heart attacks or cardiac death.
On Tuesday, researchers unveiled a large-scale, multi-year study called Courage that compared the outcomes of cardiac patients who had undergone procedures known as percutaneous coronary interventions, or PCIs, to those who used drug therapy alone. PCIs include such procedures as angioplasty with the insertion of coronary stents to keep arteries clear.
While researchers found that PCI patients experienced a higher rate of relief from angina, or chest pain, for at least three years, they also had the same rates of heart attack and cardiac death as those who had only taken cardiac drugs.
The study, which ran until 2004, primarily focused on bare-metal stents, rather than the newer drug-coated stents, which are covered with a medication designed to discourage the formation of scar tissue in the treated artery. The study was sponsored in part by Pfizer (PFE) and Merck (MRK) , which market such popular heart medications as Lipitor, Zocor and Vytorin, according to Dow Jones Newswires.
"The results weren't a huge surprise. Physicians generally use stents for symptoms relief rather than for any expected mortality benefit," wrote Caris & Co. analyst Timothy Lee, in his note on Tuesday.
Boston Scientific (BSX) and Johnson & Johnson (JNJ) are the leading marketers of drug-coated stents. Medtronic (MDT) and Abbott Laboratories (ABT) have substantial stakes in the bare-metal stent market, and both are preparing to soon enter the drug-coated stent arena.
Results from the Courage study were presented Monday at the annual meeting of the American College of Cardiology and will be published in the New England Journal of Medicine.
Analysts on Tuesday said that the Courage study just underscored what physicians have already come to expect from stent therapy.
"The trial, which compared primary coronary interventions (primarily bare metal stenting or balloon angioplasty) with optimal medical therapy (drugs alone), failed to show a mortality benefit for PCI. Said another way, stents showed no mortality or heart attack benefit over drugs alone," wrote Lehman Brothers analyst Bob Hopkins, in his note.
"This outcome, while it creates a loud headline that will be in every major paper, is exactly what was expected, as no prior trial has ever demonstrated a statistically significant improvement in mortality for stents versus drug therapy, and there have been at least six trials looking at this in the past," Hopkins added.
As a result, analysts said they don't expect physicians to change their thinking on the use of stents.
"Although headline risk remains, we suspect limited changes to practice patterns. In turn, we anticipate limited impact to the stent manufacturers, particularly Boston Scientific, which has the most exposure to DES [drug-coated stents] on a relative basis," wrote Goldman Sachs analyst Lawrence Keusch.
Piper Jaffray analysts agreed. "We do not believe this trial will result in a sustained change in cardiologist practice patterns once the media frenzy dies down and patients start listening to their doctors," the Piper Jaffray analysts said.
However, analysts did point out that negative media attention will probably temporarily dampen patient demand.
"The Courage results are likely to play on patient fears and negatively affect the market in the near-term but education should return the market to "normal" in the mid- to long-term," wrote RBC Dominion Securities analyst Douglas Miehm.
Likewise, fellow RBC analyst Phil Nalbone said that the Courage results could put further short-term pressure on sales of drug-coated stents, which have already been slowed by reports that they can carry a slightly higher risk certain patients developing blood clots than bare-metal, or uncoated, stents.
"Results of studies being released at ACC -- including the high-profile Courage trial - are likely to take a further toll on drug-eluting stent penetration levels over the next several months," wrote Nalbone.
"We said coming into the ACC meeting that we would not be surprised to see another modest erosion -- in the neighborhood of 5-percentage-points -- over the next couple of quarters," Nalbone added.
Nalbone concluded, however, that the slowdown should be temporary.
"We do not believe retrenchment in DES [drug-coated stent] use caused by Courage will last for very long. Patients may be able to put off decisions about interventional therapy without fearing any increased risk of heart attack or death, but we believe eventually elect to be treated with devices in an effort to improve their overall quality of life and function," Nalbone said.
(END) Dow Jones Newswires
03-27-07 1711ET
Copyright (c) 2007 Dow Jones & Company, Inc.
Alert Triggered for Sono-Tek Corp.
SOTK's Trading Volume Exceeded Daily Average by 236.6%
SOTK is up $0.11 or 9.65% to $1.25 on heavy volume that exceeded its daily average by 236.6%. This performance is better than the broader averages as the S&P 500 is down 0.49% on the day.
Please note you will receive only one "Trading Volume Exceeds Daily Average" alert per day for Sono-Tek Corp.
Bullish Nanotech News for MFIC at UMASS-Lowell today:
Nanotech research at UMass-Lowell
DavidBrooks | 28 March, 2007 09:39
Just south of the border, UMass-Lowell has made a surprisingly big name for itself in nanotech research, considering its size and academic heft. So they're going to show off at a public event Thursday, April 12, from 2 to 5 p.m., when more than 30 faculty members, including directors of the school's Nanomanufacturing Centers, will be on hand for poster and video presentations, group discussions and one-on-one interactions. Topics include nanoelectronics, nanomedicine, nanomaterials and the environmental health and safety of nanomaterials. They'll also discuss the newly approved $80 million nano-manufacturing facility. It will be held in the Suffolk Conference Center at Wannalancit Mills, 650 Suffolk St. It's free, although people are asked to RSVP to Elaine Dalton at (978) 934-3689 or Elaine_Dalton@uml.edu.
Source: granitegeek.area603.com
Nanotubes purify water
27 March 2007
Researchers in the US have found a new way to control the flow of water through carbon-nanotube membranes with an unprecedented level of precision. The technique, which relies on applying a small voltage to the membranes, could be used to purify drinking water and in genetic research.
Although carbon-nanotube membranes are promising candidates for filtering out small impurities and organic materials like DNA and proteins from water, the arrays are hydrophobic, that is, they strongly repel water. Now, Nikhil Koratkar and colleagues at Rensselaer Polytechnic Institute have discovered that low applied voltages can be used to manipulate the flow of water through the membranes, turning the essentially hydrophobic surfaces into hydrophilic ones. This is the first time that applied voltage has been shown to control the way that water interacts with the surfaces of these nanomaterials.
Koratkar and colleagues found that when a small positive voltage of 1.7 V was applied to the nanotube membrane, and the water had a negative potential, the nanotubes quickly switched from repelling water to pumping water. When the charge on the water was increased, the water flowed at an exponentially faster rate. In contrast, when the nanotube was made negatively charged, it took a much higher voltage of 90 V to move the water through the tube.
The team also found that they could start and stop the flow of water through the tube by simply reversing the polarity of the nanotubes. When a small positive charge was applied, the water moved through the tube and when the charge was reversed, the flow of water stopped.
Koratkar and co-workers found that the walls of the nanotubes had been electrochemically oxidized because of water electrolysis, meaning that oxygen atoms had coated the surface of the tubes. This allows water to flow through them. Once the charge was reversed, the oxidization stopped and water could no longer flow through the unoxidized portion.
Finally, the researchers observed that they could control the rate of water flow through nanotubes that were directly next to each other, allowing one tube to pump quickly while the one beside it did not pump water at all. This discovery could be important for time-released drug coatings, for instance, and lab-on-a-chip devices.
"In this century one of the big challenges is how to get clean drinking water," said Koratkar. "If you can remove salt from water you can solve this problem. Nature does this all the time. The first step to getting to this process is to control the flow of water through nanochannels, which we have now successfully demonstrated. The next step would be to capture specific proteins, DNA, or impurities within the water with specifically designed nanotubes."
The researchers reported their work in Nano Letters.
Alert Triggered for Lumera Corp.
LMRA's Trading Volume Exceeded Daily Average by 208.5%
March 28, 2007
LMRA is up $0.50 or 10.53% to $5.25 on heavy volume that exceeded its daily average by 208.5%. This performance is better than the broader averages as the S&P 500 is down 0.47% on the day.
Please note you will receive only one "Trading Volume Exceeds Daily Average" alert per day for Lumera Corp.
Emerging Stock Report! March 28, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts.
MIAMI, FL -- (MARKET WIRE) -- March 28, 2007 -- Stock Market Alerts' performance stock list includes: Aegis Industries Incorporated (OTCBB: AGIN), Apple, Inc. (NASDAQ: AAPL), Oracle (NASDAQ: ORCL), Lumera Corp. (NASDAQ: LMRA).
Lumera Corporation (NASDAQ: LMRA) up 9.9% on 1 million shares traded. Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities.
Alert Triggered for Lumera Corp.
Lumera Corp. (LMRA) Price Crossed Above Its 60 Day Moving Average
LMRA crossed above its 60 day moving average of $4.70 by a fraction of a penny. Although it is still strongly higher on the day, it is now trading at $4.69 which is below the moving average.
Please note you will receive only one "Price Crosses its Moving Average" alert per day per stock which means that you will not get another 60 day moving average alert for LMRA.
This from CVV's December 31, 2006 10-K about the First Nano division expansion plans:
In the fourth quarter of 2006, an internal decision was made to
significantly broaden the First Nano product line and pursue a
significantly larger share of the R & D market with additional
equipment platforms under the First Nano brand name. We have
begun to market, quote and manufacture these products. In the
second quarter of 2007, we plan to ship the first model of a new
series of products intended for the R & D market. We feel
comfortable we will be successful with the multiple new products
to be offered as their design is based on building blocks we
have used in previous systems over the years.
To support the increase in our existing product sales and the
development and sales of the new First Nano products, we will
need to increase our manufacturing capacity, hire additional
personnel and expand our advertising, trade shows and marketing
capabilities. Additionally, our First Nano laboratory is being
expanded with additional laboratory test equipment and the new
First Nano products for demonstration to help us stay in the
forefront of carbon nanotube and nanowire production.
Carbon Nanotube Based Body Armor Provides Alternative to Existing Bulky Materials
For Florida State University researcher Okenwa Okoli, testing his latest research is vital.
Okoli, an associate professor of industrial and manufacturing engineering in the Florida A&M University-Florida State College of Engineering, and his research team at FSU’s High-Performance Materials Institute have been working on bullet-proof body armor for U.S. military men and women.
“If I can wear it and it’s tested on me and it works, then yes, our soldiers can wear it,” he said. “The military personnel utilizing this equipment need to maneuver very quickly, and as such, the less weight they have to carry around, the better.”
Okoli has been working with nanotubes, a carbon-based material that is much smaller than a human hair but stronger than any material known to man. Nanotubes are derived from buckminsterfullerene, a unique carbon molecule that is both extraordinarily strong and light. FSU chemistry Professor Harold Kroto shared the Nobel Prize for Chemistry in 1996 with two colleagues, Richard E. Smalley and Robert F. Curl Jr., who jointly discovered buckminsterfullerene, which is better known by its nickname, “buckyballs.”
Okoli and a former colleague, Jim Thagard, developed a composite manufacturing process to create lightweight body armor using nanotubes that protects a soldier’s legs, arms and head. Metal traditionally has been used for such protective gear, but lightweight composites materials such as the ones produced by Okoli now can be used in place of heavier metals, he said.
Today, Okoli is working with the U.S. Air Force to build bulletproof body armor for the force’s parajumpers.
“Because of the weight of the current body armor systems they have, it smacks them on the back,” Okoli said. “And the momentum of jumping from such a great height and the weight of the plates throws them off target, one, and can injure them, two. So it’s not very user-friendly, even though they have to use it to protect themselves. Now, what we’ve done over the past year is create armor plates that are thinner and weigh less but still do the job.”
Okoli said there are many universities nationwide looking at lighter solutions to bulky body armor so that soldiers can better do their job in the field. However, the FAMU-FSU College of Engineering leads the effort due to its work with nanotubes.
Posted March 25th, 2007
Nanotechnology News Archive
Good post from another I-Hub MB:
Posted by: stinkeye
In reply to: shmoopy38 who wrote msg# 68531
Date: 3/27/2007 9:18:26 AM
Post #of 68550
I'll share my CVV research...
~~~PASTE~~~
03/25/07
12:46:21am
3 Business units:
CVD Division
CVD (chemical vapor deposition) is a process by which a thin layer of advanced materials is grown on top of a substrate surface (generally silicon). The process is widely used in the fields of semiconductor and sensor design, and solar cells. CVV builds the equipment that end users employ for embedding chemical vapor systems into their production lines. This unit includes certain assets of First Nano Corp that were acquired in 2005 (more on this later).
SDC Division
Stainless Design Concepts build gas delivery sub-systems for ultra high purity semiconductor clean rooms. This unit also serves as an on-site maintenance arm for CVV.
Conceptronic Division
This division markets solder reflow furnaces which are used in the printed circuit board industry (PCB). PCB's must be soldered in atmospherically controlled furnaces as the presence of oxygen results in numerous solder defects.
Breakdown of revenues by unit:
For FY2005 CVV posted revenues of $11.22mm vs. $9.7mm in 2004. Representating revenue growth of 13.7%.
2005:
CVD $4.5 (40.7%) up from 28.5% in 04
SDC $2.2 (19.5%) unchanged from 04
CPD $4.4 (39.8%) down from 48.8% in 04
The CVD unit was the growth driver in 2005 and it continues to be in 2006. The company has stated in every 10Q since acquiring First Nano that demand is strong for their carbon nanotube machinery...
~~~PASTE~~~
As a result of an increase in the number of inquiries the Company has received and proposals
the Company has submitted, the Company has experienced an increased demand
for customized CVD systems along with requests for equipment provided by
the First Nano product line.
Strong Revenue Growth in 2006:
Through the first nine months of FY06, CVV has posted a fully taxed (40%) (NOL's are nearly depleted) diluted EPS of $0.11/share. Notably nearly surpassing in 3 qtrs the $.12/share untaxed earnings booked in all of fiscal 2005.
The $.11/share through 3qtrs of '06 reflects the 40% tax rate and $129,000 in stock compensation costs ($.04/share).
Revenues grew 17% sequentially in Q3 and 28% YoY. Through the first nine months of 2006 CVV has seen revenues jump by 20%. Again, this is driven largely by the ramp in sales for the CVD unit since it's acquisition of the promising carbon nanotube business of First Nano.
Gross margins in the quarter ended 9/30/06 increased by 300 basis points to 39%. CVV has successfully managed to offset increasing labor, energy and energy costs by taking full advantage of the economies of scale the First Nano investment has brought to their CVD unit.
CVV has managed to keep SG&A flat while growing revenues and profit at a double digit pace. SG&A in Q3 would have been unchanged from the same period in 05 had it not been for the recording of $43,000 of stock based compensation which was not recognized in 05. As it stands, SG&A was up only 5% despite the aforementioned increases in labor, insurance, and energy costs.
Earnings per share before the $173k in interest expense and 40% tax rate (EBIT) puts CVV at a $.26/EPS fully diluted compared to an untaxed $.18/EPS through the first nine months of 2005.
Q4 Forecast:
Q4 of FY2005 saw CVV book roughly 27% of the year's total revenue of $11.2mm. Using that ratio as a guideline and assuming a continuation of the 20% revenue growth trend we can extrapolate the following....
Q4 revs = ~$3.5mm
margins = ~40% (lower energy and shipping costs in Q4 vs Q3)
gross profit = ~$1.4mm
selling/shipping = ~$225,000
G&A = ~$725,000
EBIT = $.14/share vs $.02/share in Q4 2005
interest expense = ~$60,000
taxes (39%) = ~$152,000
Fully diluted and taxed EPS = ~$.08/share
This would bring full year 2006 EPS (taxed and diluted) to $.19/share of a trailing P/E of 28. The growth in the CVD unit and the key markets it sells into (namely solar cells and semiconductors) should portend a continuation in the 20% growth rate witnessed in both 05 and 06.
The company has shown the ability to control G&A costs while ramping revenues and profits. Assuming they can continue to maintain margins in the ~39% area and control costs, EPS for 07 should come in at $.30. Earning CVV a forward P/E of 18. The P/E's of comparable names in the nano/semi equipment space average 28x EPS. A similar forward P/E for CVV would put the PPS at $8.40, a 57% increase from Friday's close.
Form 10KSB for CVD EQUIPMENT CORP
--------------------------------------------------------------------------------
26-Mar-2007
Annual Report
Item 6. Management's Discussion and Analysis of Financial Condition and Results of Operations.
Except for historical information contained herein, this "Management's Discussion and Analysis of Financial Condition and Results of Operations" contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, as amended. These statements involve known and unknown risks and uncertainties that may cause our actual results or outcomes to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements were based on various factors and were derived utilizing numerous important assumptions and other important factors that could cause actual results to differ materially from those in the forward-looking statements. Important assumptions and other factors that could cause actual results to differ materially from those in the forward-looking statements, include, but are not limited to: competition in our existing and potential future product lines of business; our ability to obtain financing on acceptable terms if and when needed; uncertainty as to our future profitability, uncertainty as to the future profitability of acquired businesses or product lines, uncertainty as to any future expansion of the Company. Other factors and assumptions not identified above were also involved in the derivation of these forward-looking statements and the failure of such assumptions to be realized as well as other factors may also cause actual results to differ materially from those projected. We assume no obligation to update these forward-looking statements to reflect actual results, changes in assumptions, or changes in other factors affecting such forward-looking statements.
CVD Equipment Corporation designs, develops, manufactures, markets, installs and services Chemical Vapor Deposition and gas control equipment for use in manufacturing semiconductors, solar cells, carbon nanotubes, nanowires and equipment for surface mounting of components onto printed circuit boards. Our products include (1) both batch and single wafer systems used for depositing, rapid thermal processing, annealing, diffusion and etching of semiconductor films, (2) gas and liquid flow control systems (3) ultra high purity gas and chemical piping delivery systems; (4) standard and custom quartzware, (5) reflow furnaces and rework stations and (6) carbon nanotube and nanowire deposition systems. We also provide equipment consulting, and refurbishing of semiconductor processing equipment. Our products are generally manufactured as standard products, or customized to the particular specifications of each of its customers.
Results of Operations
Revenue for the year ended December 31, 2006 was approximately $13,356,000 compared to approximately $11,225,000 for the year ended December 31, 2005, representing an increase of $2,131,000 or 19.0%. Revenue from the CVD division increased by approximately $2,297,000 to $6,863,000 which represents 51.4% of our total revenues during the current fiscal year, compared to $4,566,000, or 40.7% of our total revenues, for the prior fiscal year. The increase in demand for customized CVD equipment and gas and chemical delivery systems coupled with requests for equipment provided by the First Nano product line, which we acquired in May, 2005, has fueled this increase. The annual revenue for the year ended December 31, 2006, from our SDC division, increased by approximately $935,000 or 42.6% to $3,129,000. This represents approximately 23.4% of our overall revenue for the current fiscal year, compared to the 19.5% SDC contributed in the last fiscal year. SDC's growing reputation in the industry for quality products is the primary stimulus for this increase. Revenue from the Conceptronic division was approximately $3,364,000 for the current fiscal year a decrease of approximately $1,101,000 or 24.7% compared to $4,465,000 for the year ended December 31, 2005. The Conceptronic division is continuing to improve their product offering at the same time it is focusing its efforts towards a more solutions oriented approach with what we believe is the best heat transfer in the industry and customized products. This is being accomplished by taking advantage of the engineering expertise in the Company as a whole rather than following much of the competition which has moved manufacturing facilities to the Far East to reduce costs and thus reduce selling prices. Conceptronic has already completed its first customized product sale.
As a result of the increased revenues for the current year, cost of revenues increased to approximately $8,672,000 from approximately $7,356,000 for the last fiscal year, an increase of approximately $1,316,000. The gross profit for the current fiscal year increased to approximately $4,684,000 from last year's $3,870,000, an increase of approximately $814,000 with an increase in gross profit margin to 35.1% from the 34.5% experienced during the prior year. We continue to achieve greater gross profit margins year after year as a result of our ability to absorb those fixed costs through greater revenues and continuously monitoring costs. The gross profit margin of the CVD division increased to 42.9% for the current fiscal year compared to 42.2% for the last fiscal year. The SDC division's gross profit margin increased to 25.6% for the year ended December 31, 2006 from 19.0% for the year ended December 31, 2005. The gross profit margin of the Conceptronic division decreased during the current fiscal year to 23.3% compared to 29.4% in fiscal 2005. This primarily is a result of the division's fixed costs having a greater impact on the reduced revenues.
Selling and shipping expenses were approximately $756,000 in the year ended December 31, 2006 compared to $716,000 in the year ended December 31, 2005 representing an increase of 5.6%. This increase can be attributed to primarily to increased sales commissions and travel costs.
General and administrative expenses were approximately $2,925,000 during the year ended December 31, 2006. This was an increase of approximately $394,000 or 15.6% compared to approximately $2,531,000 during the year ended December 31, 2005. This increase can be attributed to a combination of increased payroll and benefit costs, in addition to increased general insurance and utility costs.
Other income for the current year increased to approximately $116,000, an increase of $65,000 or 127% compared to $51,000 of other income generated during the year end December 31, 2005. In 2004, we wrote off a sale to a customer that filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Bankruptcy Code, in the United States Bankruptcy Court for the District of Delaware. In 2006, the liquidating trust distributed $92,400 to us, which represented 33% of the claim.
We earned minimal interest income for both 2006 and 2005 as a result of the utilization of all of our available funds for operations.
We incurred approximately $224,000 of interest expense in the year ended December 31, 2006, which was approximately $5,000 or 2.3% greater than the $219,000 incurred in the year ended December 31, 2005. The primary source of this interest expense, approximately $179,000 in the current year and approximately $188,000 in the year ended December 31, 2005, was the interest expense on the mortgages for the two buildings we own. The increase in the balance of interest expense is due to both the higher average outstanding debt as well as the higher interest rates on our revolving line of credit in the year ended December 31, 2006 than in the year ended December 31, 2005.
At December 31, 2006, we had approximately $40,000 and $277,000 remaining of our federal and state net operating loss carryforwards respectively. For the twelve months ended December 31, 2006, we recorded income tax expense of approximately $293,000 which related to various federal, state and local taxes. The current income tax provision was reduced by approximately $49,000 as a result of the use of available net operating losses.
As a result of the foregoing factors, for the twelve months ended December 31, 2006, we earned approximately $897,000 before taxes as compared to $455,000 for the twelve months ended December 31, 2005. After tax earnings for the twelve months ended December 31, 2006 were approximately $604,000 as compared to $391,000 after tax for the twelve months ended December 31, 2005 or $.19 per basic and diluted as share compared to $.13 per basic and $.12 per diluted share for the twelve months ended December 31, 2005. We earned approximately $239,000 or $.07 per basic and diluted share for the three months ended December 31, 2006 compared to net income of approximately $62,000 or $.02 per share basic and diluted for the three months ended December 31, 2005.
Liquidity and Capital Resources
As of December 31, 2006, we had aggregate working capital of approximately $4,151,000 compared to aggregate working capital of $3,123,000 at December 31, 2005 and had available cash and cash equivalents of approximately $257,000 compared to approximately $265,000 in cash and cash equivalents at December 31, 2005.
Accounts receivable, net of allowance for doubtful accounts increased by approximately $483,000 or 25.5% at December 31, 2006 to $2,377,000 compared to $1,894,000 at December 31, 2005. This increase is attributable to timing of shipments and customer payments.
The Company sold equipment to a Customer for a purchase price of one hundred four thousand, four hundred eighty two (104,482) shares of common stock, par value $.001 per share. Between July 19, 2007 and July 31, 2007, the Company has the option to demand that the Customer make cash payment i.e.: two hundred fifty-one thousand, one hundred thirty 00/100 U.S. dollars ($251,130) for the equipment, the amount that would have been required had the Customer made cash payment for the equipment on July 19, 2006 in exchange for the return of said stock.The Customer's obligation to make such payment pursuant to the terms of the option is secured by a perfected lien upon the subject equipment and the Company's right to execute upon the aforesaid common stock. In the event the Customer does not make full payment, the Company has also reserved the right to maintain plenary proceedings against the Customer for the purpose of recovering such sums as may be due as well as the right to obtain a deficiency judgment in the event that the collateral in the equipment and stock is insufficient to discharge said obligation.
Inventory as of December 31, 2006 was approximately $2,705,000 representing an increase of approximately $637,000 or 30.8% over the inventory balance as of December 31, 2005. The increase in inventory was comprised of a slight increase in raw materials of approximately $11,000, an increase in work in process of approximately $662,000 and a decrease in finished goods of approximately $35,000. The build-up in work in process is indicative of an increase in orders that we are experiencing in addition to our transition to building a more standardized product line in order to reduce the time needed to fill a customer's order. Custom orders still comprise a significant part of our revenues. Accounts payable at December 31, 2006 was approximately $651,000 or 1.7% higher than it was at December 31, 2005.
In 2006 our credit line with a bank which permits us to borrow on a revolving basis was revised to reflect an increase in the amount we are permitted to borrow from $1,000,000 to $1,250,000. 13 All financial covenants previously limiting the amounts borrowed were eliminated. The line of credit is subject to renewal on June 1, 2007. As of December 31, 2006, the outstanding balance on this facility was $210,000 as compared to $100,000 at December 31, 2005.
We also have an available $250,000 line of credit for equipment purchases from the same bank permitting us to borrow up to 100% of the purchase price of equipment. The amount borrowed is immediately converted into a five year term loan at the bank's prime rate plus 1 1/4%. As of December 31, 2006, there was approximately $77,000 outstanding on this facility. Borrowings under this facility are collateralized by the equipment purchased.
In March, 2002, we received from General Electric Capital Corporation a $2,700,000 mortgage loan, secured by the real property and building and improvements to finance and improve our facility in Ronkonkoma, New York. The mortgage loan, which has an outstanding balance as of December 31, 2006 of $2,075,148, is payable in equal monthly installments of $22,285 including interest at 5.67% per annum; pursuant to an industrial development bond purchase agreement with the town of Islip Industrial Development Agency. The final payment is due March 2017.
In April, 1999 we received from Kidco Realty Corporation a $900,000 purchase money mortgage loan, secured by the real property, building and improvements in Saugerties, New York. The mortgage loan has an outstanding balance at December 31, 2006 of $810,508 and is payable in equal monthly installments of $5,988 including interest at 7% per annum. The entire principal balance is due May 2009.
In the fourth quarter of 2006, an internal decision was made to significantly broaden the First Nano product line and pursue a significantly larger share of the R & D market with additional equipment platforms under the First Nano brand name. We have begun to market, quote and manufacture these products. In the second quarter of 2007, we plan to ship the first model of a new series of products intended for the R & D market. We feel comfortable we will be successful with the multiple new products to be offered as their design is based on building blocks we have used in previous systems over the years.
To support the increase in our existing product sales and the development and sales of the new First Nano products, we will need to increase our manufacturing capacity, hire additional personnel and expand our advertising, trade shows and marketing capabilities. Additionally, our First Nano laboratory is being expanded with additional laboratory test equipment and the new First Nano products for demonstration to help us stay in the forefront of carbon nanotube and nanowire production.
We believe that our cash and cash equivalent positions, cash flow from operations and ability to expand our credit facilities will be sufficient to meet our working capital and investment requirements for the next twelve months, including modest growth, without shareholder dilution.
Should we determine to grow our business more aggressively, which may include making acquisitions, we may need to raise additional funding. For this reason, as well as other reasons that arise from time to time, we may consider raising capital through equity or debt financings. Any decision to raise additional capital, as well as the determination of the appropriate vehicle for doing so, will depend on market conditions, order levels, opportunities presented to us and other factors.
Significant Accounting Policies
We continue to recognize revenues and income using the percentage-of-completion method for custom production-type contracts while revenues from other products are recorded when such products are accepted and shipped. Profits on custom production-type contracts are recorded on the basis of our total estimated costs over the percentage of total costs incurred on individual contracts, commencing, when progress reaches a point where experience is sufficient to estimate final results with reasonable accuracy. Under this method, revenues are recognized based on costs incurred to date compared with total estimated costs.
The asset, "Costs and estimated earnings in excess of billings on uncompleted contracts," represents revenues recognized in excess of amounts billed.
The liability, "Billings in excess of costs on uncompleted contracts," represents billing in excess of revenues recognized.
Off-Balance Sheet Arrangements
None
Alert Triggered for CVD Equipment Corp.
CVD Equipment Corp. (CVV) Price Crossed Above Its 60 Day Moving Average
CVV crossed above its 60 day moving average of $5.52 with a trade of $5.60 at 9:56 AM EDT, up 2.2% from the moving average.
Please note you will receive only one "Price Crosses its Moving Average" alert per day per stock which means that you will not get another 60 day moving average alert for CVV.
Alert Triggered for Nano-Proprietary Inc.
NNPP Reached a New 52 Week High at $2.96
NNPP rose 0.7% to a new 52 week high of $2.96. During the last 52 weeks, NNPP's price has ranged from $0.92 on November 9, 2006 to today's high of $2.96.
Please note you will receive only one "New 52 Week High" alert per day for Nano-Proprietary Inc.
Arrowhead's Carbon Coup
The Motley Fool
By Jack Uldrich
March 23, 2007
In the field of nanotechnology, few materials have generated as much excitement as carbon nanotubes. Their high strength-to-weight ratio, small size, and excellent conductivity hold the potential to open up a host of business applications in flat-panel displays, conductive polymers, high-strength materials, solar-energy converters, and electronics.
For years, one of the better-recognized leaders in this field has been Carbon Nanotechnologies, a privately held company based in Houston. Yesterday, the company's status changed, when Unidym, a subsidiary of Arrowhead Research (Nasdaq: ARWR), announced that it has purchased Carbon Nanotechnologies for $5.4 million. As a result of the deal, Arrowhead's stock surged 15%.
On the face of it, there's no question that acquiring Carbon Nanotechnologies' intellectual property alone adds significant value to Arrowhead. The company is one of the world's leading producers of carbon nanotube; it owns 54 patents and has dozens more pending, and it boasts established relationships with DuPont (NYSE: DD), Motorola (NYSE: MOT), and Foster-Miller.
The bigger question for investors is whether Unidym will be able to translate this intellectual property into commercial products that generate revenues and, eventually, profits.
I think it will happen, but not overnight. According to company officials, Unidym will focus first on incorporating carbon nanotubes into electronics products. Specifically, it intends to have a transparent electrode on the market next year. Unidym believes that product will replace tin-oxide electrodes in the touchscreens on cell phones and PDAs. After that, it is looking at developing RFID tags, thin-film transistors for the printable-electronics industry, and possibly even carbon nanotubes as drug-delivery vehicles.
The market for the transparent electrodes is an estimated $1 billion, and if Unidym can capture even a portion of that pie, the value of the stock will rise. But I would caution investors that electronics manufacturers are typically not quick to adopt new technologies. And although tin oxide has its shortcomings, it is not at all clear yet that carbon nanotubes -- for all their amazing properties -- don't also have problems of their own. This is especially true in terms of trying to manufacture each nanotube so that it has the exact desired property.
These reservations aside, the acquisition is a solid, strategic move, and it should bolster Arrowhead's position in the long term. Like Motley Fool Rule Breakers recommendation Harris & Harris (Nasdaq: TINY), the publicly traded venture-capital firm specializing in nanotechnology, it is a more speculative investment. But if carbon nanotubes can begin to deliver on their immense potential, an investment in Arrowhead could pay significant dividends in the years ahead.
Alert Triggered for Nano-Proprietary Inc.
NNPP Reached a New 52 Week High at $2.91
NNPP rose 0.7% to a new 52 week high of $2.91. During the last 52 weeks, NNPP's price has ranged from $0.92 on November 9, 2006 to today's high of $2.91.
Please note you will receive only one "New 52 Week High" alert per day for Nano-Proprietary Inc.
Alert Triggered for CVD Equipment Corp.
CVV's Trading Volume Exceeded Daily Average by 210.7%
CVV is up $0.09 or 1.69% to $5.40 on heavy volume that exceeded its daily average by 210.7%. This performance is in-line-with the broader averages as the S&P 500 is up 0.02% on the day.
Please note you will receive only one "Trading Volume Exceeds Daily Average" alert per day for CVD Equipment Corp.
DEMAND FOR NANOTECH MEDICAL PRODUCTS TO RISE TO $110 BILLION IN 2016
Source: www.fdanews.com
March 22, 2007
Demand for nanotechnology medical products will grow by more than 17 percent annually to reach $53 billion in 2011, according to a recent report from The Freedonia Group. By 2016, new products such as nanodiagnostics, nanotech-based medical supplies and nanomedicines will drive demand to more than $110 billion, the report added.
Advances in nanotechnology will enhance the quality and performance of diagnostic products, the group said. For example, nanosized monoclonal antibody labels and DNA probes will improve the speed, accuracy, capabilities and cost effectiveness of in vitro diagnostic testing.
Nanoparticle formulations of superparamagnetic iron oxide, gadolinium, perfluorocarbon and specialty polymers used for in vivo imaging would allow the detection of tumors, plaque, genetic defects and other diseases at earlier stages and with lower, safer concentrations of injected compounds, the report said.
Freedonia anticipated these performance advantages and the broadening range of nanodiagnostics will increase demand for these products by 8.8 percent per year to reach $8.4 billion in 2011 and $12 billion in 2016.
Nanotechnology will also have greater applicability in medical supplies and devices, the group said, noting that nanomaterials are already used as active ingredients in burn dressings, bone cement, bone substitutes and dental repair and restoration products.
The group predicted that the long-term impact of nanotechnology will include new medical supply and device coatings, as well as new medical implants. In 2011, the market for nanomaterial-based medical supplies and devices is expected to hit $5.2 billion, compared with $400 million in 2006. This figure will reach $16.2 billion in 2016, the group predicted, as nanotech-based orthopedic and cardiac implants and nanocoated medical and surgical instruments are introduced.
In 2006, the five largest nanotech suppliers to the U.S. were Genentech, Johnson & Johnson, Abbott Laboratories, Amgen and Roche, with nearly 60 percent of the $23.6 billion U.S. market.
Congrats. to Dr. Worm:
Alert Triggered for Nano-Proprietary Inc.
NNPP Reached a New 52 Week High at $2.65
NNPP rose 5.7% to a new 52 week high of $2.65. During the last 52 weeks, NNPP's price has ranged from $0.92 on November 9, 2006 to today's high of $2.65.
Please note you will receive only one "New 52 Week High" alert per day for Nano-Proprietary Inc.
Food nanotech news:
Functional stabilisers nanoengineered for foods
www.foodproductiondaily.com
By Ahmed ElAmin
Report tips top flavours for 2007
The evolution of the nanotech revolution
Nano scale coating process developed for baking sector
Ozone nano-bubbles harnessed to sterilise water
Nano project aims to reduce packaging waste
Denmark food research to focus on emerging technologies
EU agency sets food safety agenda for year
20/03/2007 - Dairy proteins and polysaccharides can be nanoengineered as new functional stabilisers for foods and packaging, according to scientists working on a project in Finland.
The government-sponsored Tailored Nanostabilisers for Biocomponent Interfaces Project (Taina) aims to engineer and construct functional nanoscale particles for sensitive biocomponents in foods.
Nanotechnology deals with controlling matter at near-atomic scales to produce unique materials, products and devices. It has been touted as the next revolution in many industries, including food manufacturing and packaging.
Tekes, the main public funding organisation for research and development in Finland, has provided €1.4m over three years for the food project.
Markku Lämsä, a senior technology advisor with Tekes, told FoodProductionDaily.com that the believe that the particles can act as active emulsions, to stabilise foams and sensitive components during processing or in the gastro-intestinal tract.
The scientist involved also want to develop tailored barrier and sensing functions for food packaging using the components.
For food packaging, they aim to improve the barrier properties of the biopolymers and also to evaluate the possibility to incorporate enzymes in nanoscale particles into the packaging materials.
Such use of enzymes would give increased functionality or "intelligence" to the package, such as freshness indicators, he said.
"The project focuses on interfacial engineering of dairy proteins and polysaccharides to improve their antixodant properties, emulsion stability, barrier properties and protection against other bioactive components," he said.
They are working on the premise that proteins and selected carbohydrates are suitable as nanostabilisers for bioactive components, he said.
Enzymes can be used as tools to add novel functionalities to such polymers, they believe. Micro-organisms can also be used to produce proteins with unique potential for nanoscale applications.
"These hydrophobins have strong self-assembling nature and they are good candidates when nanoscopic structural organisation in biomaterials is desired," according to a description of the project.
The project partners are VTT , Åbo Akademi, Helsinki University of Technology and the Institute for Surface Chemistry in Sweden.
The project forms part of Finland's programme to develop nanotechnology expertise within the country.
Finnish industry and Tekes are drawing up a shared strategy on nanotechnology development targets. The safety of nanotechnology applications is one of the key themes.
"We want the practical implementers to have a say in choosing the target areas of financing. The work began last spring with the creation of a joint vision by the electronics, chemical and forest clusters, and now continues in a more concrete way as the allocation of financial resources," Lämsä said.
The programme's six thematic groups focus on the electronics and forest clusters, nanotechnology processes and instruments, nanotechnology materials and safety.
Commercial products include nanoscale particles and materials, but also an increasing amount of products relying on 'applied' nanotechnology, such as cosmetics and paints.
The thematic groups began their work on 30 August. The work will continue until the end of 2010.
Safety was selected as one of the themes because the safety risks of nanoparticles have aroused debate particularly among health-care and medical researchers worldwide, Lämsä said.
Public concerns have been raised that nanostructured materials could potentially lead to unforeseen health or environmental hazards. In the food area fears arise over the unknown consequences of digesting nano-scale particles designed to behave in specific way in the body.
About 80 companies using nanotechnology participate in Tekes' FinNano technology programme.
A 2006 survey identified 129 Finnish companies that either had commercial products or research activities focused on nanotechnology, or who had participated in the Tekes FinNano technology programme.
Of the identified 129 firms, 29 reported having a commercial product which is based on nanotechnology. These products range from technology for industrial processes to consumer products.
Activity has been especially strong in the areas of packaging, with increased research into 'intelligent' packaging, incorporating features like freshness indicators, the survey found.
MFIC 2.37 +.07 is inching up towards its recent high and is a highly desirable stock to own IMHO. MFIC is a profitable, nanotech stock with a thin float and a $23 Million market cap that looks to be on the cusp of J-curve growth in revenues and EPS.
NNBP - chart - has it finally leveled off?
Just for fun: Here is what Steve Forbes is saying about Forbes/Wolfe Nanotech Report:
Tuesday, March 20, 2007
Forbes Top 5 Nanotech Stocks to Buy Now
Even during their high-flying heydays, the returns of eBay, Google, Intel and Microsoft will likely pale in comparison to the rewards you could reap from these rising Nanotech stock stars!
I invite you to try out the only nanotech-exclusive stock report approved by me that has rewarded Forbes readers with an astounding +122.50% total return since March 2002. Compare this to only +37.38% for the Nasdaq and just +25.80% for the S&P 500 during this same time period!
Plus, if you respond today, you’ll also receive a total of 4 Special Reports on nanotech investing, including 2 that are hot off the presses!
Dear Friend and Ever-Vigilant Investor,
I know you’ve been waiting patiently for another chance like this to come along.
Ever since the dotcom bubble burst!
The fact is, most investors have been biding their time in the market these past several years; waiting for stocks to EXPLODE once again with…
30%, 50% or even TRIPLE digit annualized returns!
Well, I’m pleased to report that your patience is about to be rewarded. They’re here. They’re happening. And they’re now.
So buckle your seatbelt and get ready for the ride of your investing life. Because from this humble editor’s well-positioned vantage point, this will be…
Your best chance to profit from the greatest technological boom of the 21st century!
No doubt you’ve heard about this remarkable new technology—or nanotechnology to be more precise.
Every investing “guru” has been touting its merits and potential.
It’s been picked apart and bandied about on all the financial news shows.
Whenever you thumb through a publication—including one with the Forbes name on it—you hit on at least an article or two about the subject.
And industries, businesses, consumers (why even entire nations) have already embraced nano’s promising new advances and breakthroughs with such open arms that it’s turned…
A science fiction writer’s ultimate fantasy into everyday REALITY.
“This next revolution (nanotech) is at least as fundamental as the IT
revolution has been. It is not hyperbole to say it will change everything; every facet of industry.”
- Phillip Bond, Former Chief Science and Technology Advisor to the U.S. Secretary of Commerce.
Just consider what nanotech has in store for us all:
Sugar-cube-sized supercomputers that can store everything ever published.
Combat fatigues that detect toxins and biological weapons and then instantly secrete blocking agents — and change color like a chameleon to blend with the surroundings.
Antifreeze proteins that prevent damage during low-temperature transport of human organs for transplant.
Windows, kitchens and bathrooms that never need cleaning — new tiles are on the way that are 100% dirt-proof
Bio-composites smaller than a human cell that will make your bones and tendons super strong.
Of course, that’s just a small sampling of how extensively nanotech has already pervaded society. But the simple fact is…
There’s no limit to how far nanotechnology will one day reach into every aspect of our lives.
Frankly, I haven’t witnessed such exciting prospects for science and technology stocks—or such potential for profits—since, well, back in the early ’90s. When Internet stocks began to drive the market.
Back then, fortunes were made as “The Information Age” was wrested from the exclusive control of powerful universities and research firms and shared with millions of typical, everyday people.
The very same scenario is shaping right now for the leading nanotech companies. More and more investors are eagerly looking into them. And their stocks are already gaining momentum.
“Discoveries involving nanoscience will be as dramatic and, I believe, even more important than the creation of the Internet.”
- Newt Gingrich, Former Speaker of the U.S. House of Representatives
To investors like you and me, such ability to transcend and transform so many diverse industries, companies and individual products—products that you and I buy and use each and every day—coupled with its “snowball” effect on world markets means just one thing…
Opportunities for making money!
I can assure you, there will be an endless source of them, as nanotech advances into the future.
What’s even more important, you have plenty of time to get into these stocks while it’s still early. Before they take off! And you can ride them for as long as the bulk of the profits can be made.
But being the prudent investor that you are…
You must always remain selective. And cautious.
Not every nanotech stock will be worth investing in.
Many will be fraught with pitfalls. Others will become overbought. And some nanotech firms that haven’t even made a sale, never mind a profit, are already being over-pitched.
It’s almost like déjà vu all over again.
You certainly recall what can occur when a sector or a company takes off for no good reason. When stocks are bought on “speculation” rather than on solid financial analysis. When earning reports become overblown. When sales deals fizzle. And when, unfortunately, average individual investors are left holding the bag.
Who can forget the Internet crash just a few short years ago?
Billions of dollars were collectively lost in the market by uninformed investors.
For every multi-billion dollar Google and eBay success story, there were hundreds of companies that—while looking great on a daily stock board—were really nothing more than mere smoke and mirrors.
Many of those firms eventually vanished into thin air. And with them, the hard-earned money of good, average citizens like you.
For all those reasons and more, you should know about…
The Forbes/Wolfe Nanotech Report.
“The Forbes/Wolfe Nanotech Report shows investors a rare insider’s view into the nanotech revolution and will give investors the edge they need to compete in the field.”
- Charles Musgrave, Ph.D., Stanford University (Awarded the first Feynman prize in Nanotechnology, 1993)
Edited by my friend, Josh Wolfe, the Forbes/Wolfe Nanotech Report contains all the trends, tools, tips and talk that can make you a more successful and much richer nanotech investor.
There’s no one better qualified to show you the way.
If there’s anything that might possibly affect (or does affect) the prices or dividends of the nanotech stocks he follows, I can assure you, Josh is on top of it. He knows nanotech inside and out.
He has to.
Josh is the Managing Partner of one of the world’s leading venture capital firms specializing in nanotech investments. His firm funds millions of dollars to companies looking to gain a foothold in the marketplace, edge out competitors and race to the forefront in their respective fields. His Rolodex is a veritable Who’s Who of nanotech CEOs, CFOs, R&D executives and government officials.
For the Forbes/Wolfe Nanotech Report, Josh has assembled a team of investment experts, research scientists, reporters and other contributors. Together they delve into the glut of nanotech news, financial data and developments… filter it all down into simplest terms… and deliver it all to you in one easy to read, easy to follow monthly Report showing the best ways to capitalize on these exciting breakthroughs NOW!
Here’s what you get:
Feature Stories – Want a quick, expert outlook on important trends and developments in nanotech? This section brings you to where it’s all happening across the globe or right in your own hometown. Find out what new products are hitting the street… ideas and research that will lead the nanotech charge… and the start-ups, IPOs and established firms that are making news.
Follow the Money – Grants and private research fundings are excellent indicators of potential investment opportunities. Discover which companies are on the receiving end, how they’ll use it to fund their nanotech ventures and the potential benefits to all – including YOU, as an investor.
Companies to Watch – Each month, the Forbes/Wolfe Nanotech Report brings you inside two or three companies. Learn about their ground-breaking products and applications. Meet their executive teams. And see why Wall Street will be buzzing about their stocks—before other investors!
Word on the Street – Understanding the forces that can influence your stock’s performance is crucial. Especially when your investments are focused on a new and rather complex environment like nanotech. Our team of investment experts and scientists help you sort through the market “noise” and decide whether you should increase your holdings, stay in a holding pattern, or cash in your winnings.
Thinking Small – You can learn a lot by sitting down and getting to know someone. And in this section you’ll get to know the leading research scientists, entrepreneurs, executives and venture capitalists in all of nanotech up close and personal. Find out what they have to say about where their industry and respective companies are heading with in-depth conversations and Q&A sessions. Their insights and perspectives will prove to be a wealth of information to guide you in making your own investment decisions.
The Nanosphere – It can’t get any clearer than this! Specific BUY, SELL and HOLD ratings for each company listed makes no bones about what to do with your money. Or in how to make the most from it. The listing is updated monthly (in addition to frequent email alerts between issues) so you can always stay on top of your investments and ahead of the game and other investors with our latest nanotech news, analysis and insights.
Profit Alert! Profit Alert! Profit Alert!
The Forbes/Wolfe Nanotech Report’s stock recommendations are now UP a whopping 122.50% total since March 2002.
Here are just a few recent winners we spotted for subscribers as of 3/19/2007:
Flamel [FLML] - Initiated coverage on 08/02 at $1.60. Currently $29.34 per share. A 1,734% gain!
Harris & Harris [TINY] - Initiated coverage on 05/02 at $3.60. Currently $11.81. A 228% gain!
Hewlett-Packard [HPQ] Initiated coverage on 03/02 at $20.12. Currently $40.21. A 99.9% gain!
FEI [FEIC] - Initiated coverage on 01/03 at $18.75. Currently $35.16. An 87.5% gain!
Our latest issue and recommendations are being prepared right now. Don’t waste another second to jump on an opportunity. One idea or one recommendation on a great nanotech stock can make you a fortune or save you one. Just click here to subscribe now.
But that’s not all you get!
Your personal monthly Reports are emailed to you throughout the year, plus there are special email alerts that instantly update you with all our current recommendations. You can also access your current Forbes/Wolfe Nanotech Report and the complete historical archive online—whenever and wherever it’s convenient.
You also receive:
FREE Bonus #1: 5 Biggest Profit-Takers of the Nanotech Revolution
Discover Josh Wolfe’s own handpicked current favorite nanotech stocks. Obscure at the moment to most of Wall Street, these companies are soon bound for glory. And making a fortune on these stocks could be as simple as getting in early. Included you’ll find detailed company profiles… website links… revenue and P&L statements… financial projections… competitive analysis… nanotech product lines… and much more.
FREE Bonus #2 (Just Released!): How Nanotech Will Help Win the War Against Terror
Since 2001, the Department of Defense alone has spent $1.2 billion on advancing nanotech solutions that can help minimize the potential impact of terrorist activities and enhance our ability to win the war. You’ll get a Board Member’s look at the companies that are receiving impressive funding. You’ll learn about the nanotech materials and applications that companies are creating and delivering to each branch of the military. Plus you’ll see how average citizens will benefit from non-military uses of these nanotech products and methods.
FREE Bonus #3 (Just Released!): How Nanotech Will Save You Money at the Pump
Get an “insider’s” view of the big players and rising stars that are right now working to reduce America’s dependence on foreign oil and save us from ever-spiraling gas prices. Find out about the latest advanced materials being developed, catalysts and other discoveries, plus the nanotechnologies that will change the world we live in. It’s heads-up information like this that can position you for HUGE rewards with your stocks!
FREE Bonus #4: Nanotechnology 101
Feeling unsure of what nanotech is all about or how you can benefit as an investor? This valuable Special Report will make you an expert in just 20 minutes. In plain English, Josh Wolfe unravels the complexities and mysteries in order to guide you to certain opportunities from nano-investing.
Here’s where you come in…
Perhaps you’re already investing in nanotech stocks. Or maybe you’re just interested and want to know more about them. (Who wouldn’t?)
That alone would be reason enough to subscribe to the Forbes/Wolfe Nanotech Report.
Your returns from just one profitable stock recommendation could more than pay for your subscription dozens of times over. And you certainly have to agree that the Forbes/Wolfe Nanotech Report is well worth looking into even if you just want to satisfy the inquisitive scientist in you.
But what’s even more important is, if you’re planning to be in the stock market in any shape or form during the next several years, the Forbes/Wolfe Nanotech Report will become the one and only resource you should rely on to guide you.
It doesn’t matter whether you made an fortune from your stocks when the Internet led the last bull market, or whether you’re kicking yourself for missing out entirely on that opportunity. It doesn’t even matter if you lost your shirt when the proverbial mud hit the fan.
Nanotech is here to stay. And you absolutely cannot, YOU MUST NOT miss out on all the phenomenal opportunities to make money that this unique Report can deliver to you in the months and years ahead.
The Forbes/Wolfe Nanotech Report lays out a game plan for you to achieve your financial goals and grow wealthy beyond your wildest imagination—starting today. Plus it helps you to protect your nestegg like no other publication can.
So what are you waiting for?
Just click here to subscribe now.
Please, I urge you, don’t miss out on even a single recommendation, idea or opportunity. Start your subscription now and receive our latest issue right away.
Your satisfaction is guaranteed.
Being at the helm of the world’s premier financial information firm, as you can imagine, I take my job and the satisfaction of our subscribers very seriously.
I believe in and stand behind the Forbes/Wolfe Nanotech Report 100%
So if for any reason you don’t believe as I do that your subscription is a great value and giving you your complete money’s worth, just tell us. We’ll reimburse you for all the issues remaining in your subscription, with no questions asked and no hard feelings.*
There’s no better deal I can give you than that.
Just click here to subscribe now.
I can assure you, you’ll be well rewarded. Do it now.
Yours for greater, safer nanotech profits,
Steve Forbes
President and CEO
Forbes
P.S. In a fast-changing field like Nanotechnology, investment opportunities appear and disappear at a moment’s notice. Each issue of the Forbes/Wolfe Nanotech Report plus all four of your FREE Bonus Reports are, therefore, very time-sensitive. Just click here to subscribe now to be sure you’re getting the latest news, analysis and advice from Josh Wolfe and his team of nanotech experts. You don’t want to miss the next big nanotech winner.
P.P.S. Remember, you can cancel at anytime if you’re not completely satisfied. And you still get to keep all the FREE Bonuses and Reports you have received to boot. So really, nothing should be holding you back. Just click here to subscribe now.
* Monthly subscriptions are not eligible.
All figures reported as of 3/16/2007.
Alert Triggered for FEI Co.
FEIC Reached a New 52 Week High at $35.61
FEIC rose 1.3% to a new 52 week high of $35.61. During the last 52 weeks, FEIC's price has ranged from $18.78 on August 10, 2006 to today's high of $35.61.
Additionally, over the last 12 months, FEIC has increased 78.14%.
Please note you will receive only one "New 52 Week High" alert per day for FEI Co.
NVE Corp. breaks above opening range, next resistance is at last wk's high of 28.50-- session high 28.10.
Briefing.com - March 20, 2007 10:09 AM ET
Alert Triggered for Sono-Tek Corp.
Sono-Tek Corp (SOTK) Price Crossed Above Its 60 Day Moving Average
SOTK crossed above its 60 day moving average of $1.14 with a trade of $1.15 at 10:43 AM EDT, up 6.5% from the moving average. It is currently trading strongly higher on the day, up 4.5% to $1.15.
Please note you will receive only one "Price Crosses its Moving Average" alert per day per stock which means that you will not get another 60 day moving average alert for SOTK.
NVE Corp. (NVEC) notified of grant of VMRAM patent
8:01 AM EDT March 20, 2007
Co. announces it has been notified by the U.S. Patent and Trademark Office of the expected grant of a patent relating to Vertical Transport Magnetoresistive Random Access Memory. The co has been notified that the patent, titled "Radial field generating selection conductor device," will be issued today. The patent is number 7,193,286 and is the grant of a patent under the application published by the USPTO as number 2006-0022238. The new patent relates to addressing Vertical Transport MRAM arrays.
Source: Briefing.com
Lumera Secures Million-Dollar Contract for Wideband Optical Modulators
Tuesday March 20, 9:00 am ET
BOTHELL, Wash.--(BUSINESS WIRE)--Lumera Corporation (NASDAQ:LMRA - News), a leader in the emerging field of nanotechnology, announced today that it has been awarded an extension to a U.S. government contract to continue development of technologically advanced wideband optical modulators. The 12-month contract is valued at approximately $1.15 million; the overall contract value has now reached approximately $6.9 million.
"This is further validation of the superiority of our electro-optic devices and materials and, along with other Lumera government contracts, directly parallels our roadmap to commercial products," said Tom Mino, Chief Executive Officer of Lumera. "Being chosen is recognition of our performance in meeting the technical and financial milestones defined in the contracts."
Lumera is developing high-performance modulators which enable a new generation of fiber-optic systems that are expected to deliver increased bandwidth at competitive costs and use lower power than current devices.
About Lumera
Lumera is a leader in the emerging field of nanotechnology. The company designs proprietary molecular structures and polymer compounds for the bioscience and communications/computing industries, both of which represent large market opportunities. The company also has developed proprietary processes for fabricating such devices. For more information, please visit www.lumera.com.
Certain statements contained in this release are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the company's forward-looking statements include the following: market acceptance of our technologies and products; our ability to obtain financing; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards and to develop partnership opportunities; the timing of commercial product launches; the ability to achieve key technical milestones in key products; and other risk factors identified from time to time in the company's SEC reports, including its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q.
Contact:
Lumera Corporation
Helene Jaillet, 425-398-6546
hjaillet@lumera.com
or
The Summit Group Communications
Todd Wolfenbarger, 801-595-1155
801-244-9600 cell
--------------------------------------------------------------------------------
Source: Lumera Corporation
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |